Welcome to our dedicated page for Sono Tek SEC filings (Ticker: SOTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Sono-Tek Corporation (Nasdaq: SOTK) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Sono-Tek is incorporated in New York, and its recent filings include multiple current reports on Form 8-K and a definitive proxy statement on Schedule 14A, all of which help investors understand the company’s operations, governance, and material events.
Recent Form 8-K filings for Sono-Tek cover results of operations and financial condition, including quarterly earnings releases, as well as material orders such as multi-million dollar medical device coating system contracts. Other 8-Ks report on shareholder meeting presentations and voting outcomes, including director elections, auditor ratification, and advisory votes on executive compensation and the frequency of such votes.
The company’s definitive proxy statement (DEF 14A) outlines matters submitted to shareholders at the annual meeting, such as the election of directors and approval of auditors, and provides detail on governance structure and compensation policies. Together with periodic reports not listed here, these filings form the core regulatory record for SOTK.
On Stock Titan, Sono-Tek’s filings are updated in near real time from the SEC’s EDGAR system. AI-powered summaries help explain the key points of lengthy documents, so readers can quickly see what changed in a quarter, how large orders are disclosed, or how shareholder votes were cast. Users can review 8-Ks for earnings and major contracts, proxy materials for governance information, and other filings to build a fuller picture of Sono-Tek’s financial reporting, risk disclosures, and corporate actions.
Sono-Tek Corporation (SOTK) insider filing: CEO Stephen R. Harshbarger reported an option grant on 08/21/2025. The report shows acquisition of 29,268 Sono-Tek options with an exercise price of $3.25 per share.
The options become exercisable on 08/21/2026 and expire on 08/21/2035. Following the reported transaction, Mr. Harshbarger beneficially owns 83,184 shares (direct).
Sono-Tek Corporation filed a current report describing information shared at its annual meeting of shareholders. On August 21, 2025, the company provided a presentation at the meeting, which is furnished as Exhibit 99.1. The disclosure is made under the sections for results of operations and financial condition and for Regulation FD, but the materials are expressly treated as “furnished” rather than “filed,” meaning they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other securities law filings.
Stephen J. Bagley, CFO of Sono-Tek Corporation (SOTK), reported multiple open-market sales of common stock on August 18-19, 2025. The filings show four dispositions at prices between $3.34 and $3.36 per share, reducing his direct holdings stepwise to 34,254 shares. The Form 4 is signed and filed to disclose these changes in beneficial ownership.
Stephen J. Bagley, CFO of Sono-Tek Corporation, reported a sale of 350 shares of common stock on 08/07/2025 at $3.33 per share. After the transaction he directly beneficially owns 36,147 shares. The Form 4 shows only this routine officer sale and lists no derivative transactions or other material changes to his ownership.
Sono-Tek Corp. (SOTK) mailed its DEF 14A for the 21 Aug 2025 AGM (record date 21 Jul 2025, Milton NY, 10 a.m.). Shareholders will:
- Elect four directors (Coccio, Riemer, Harshbarger, Warshaw) to 2027.
- Ratify CBIZ CPAs as independent auditor, replacing Marcum after its business sale.
- Cast advisory votes on NEO compensation and on pay-vote frequency (board backs three-year cycle).
Board consists of eight members—six are NASDAQ-defined independent. Dr Christopher Coccio became Executive Chair in Jan 2024; R. Stephen Harshbarger is CEO. FY 2025 NEO pay: CEO $385.5k (incl. $60k option grant at $4.12), CFO $254.6k, COO $334.8k. Non-employee directors earn $2,500 per meeting plus 5,333 options.
Equity plans: 2013 Plan (211k options outstanding, closed) and 2023 Plan (220k outstanding, 2.5 m share limit). Change-of-control severance equals two years’ comp (CEO estimate $659k). Outstanding shares total 15.73 m; Emancipation Management and related entities own 34.8%. Audit fees FY 2025 were $185k; no tax or other fees. Board recommends voting FOR all proposals.